A naukri.com initiative
Bioengineer
4d
81
Image Credit: Bioengineer
Acoustic Holograms Unlock Multi-Target Brain Therapy
- Researchers have introduced a novel ultrasound-based technology, AH-SiMBO, for opening multiple regions of the blood-brain barrier simultaneously and precisely.
- AH-SiMBO addresses the challenge of delivering therapeutic agents to the brain by offering non-invasive and targeted solutions for neurological disorders.
- The technology utilizes acoustic holography to generate complex ultrasound patterns that can open multiple BBB sites concurrently with high accuracy.
- AH-SiMBO's multi-focal approach reduces treatment durations and enhances efficiency in treating a wide range of neurological conditions.
- Extensive preclinical studies have demonstrated the safety and precision of AH-SiMBO in selectively opening the BBB without causing adverse effects or cumulative damage.
- The platform's adaptability allows tailored interventions for various neurological disorders by adjusting ultrasound parameters and treatment maps based on individual patient needs.
- AH-SiMBO's compatibility with existing imaging modalities facilitates real-time monitoring, ensuring precise treatment delivery and minimizing risks.
- The technology opens new avenues for gene therapy, antibody delivery, and immune modulation within the central nervous system, potentially transforming disease management.
- Clinical trials are underway to evaluate AH-SiMBO's efficacy in treating neurological conditions and exploring collaborations with pharmaceutical companies for enhanced drug delivery.
- AH-SiMBO represents a transformative technology in neurological therapeutics, offering a promising solution to overcoming barriers in treating brain disorders with precision and speed.
Read Full Article
4 Likes
For uninterrupted reading, download the app